Alzheimer's Disease

Alzheimer’s disease (AD) is a primate-specific progressive neurodegenerative disease that occurs gradually and results in memory loss, deleterious behavioral and personality changes. The phenotype is related to the death of hippocampus and temporal gyrus neurons and the breakdown of the connections between them. Nerve growth factors (neurotrophins) decline decades before clinical symptoms with Aβ amyloidosis and neurofibrillary tangles in brain. NeuroQR develops human neurotrophins and anti-brain-inflammation compounds for early intervention of AD susceptible individuals. NeuroQR designs neurotrophin and therapeutic oligonucleotide adeno-associated virus for gene therapy and provides multiplex TaqMan and semiconductor sequencing primer sets to detect AD vulnerable genes.

US Patent
Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof
Liu QR. , inventor. NIDA/NIH, assignee. United States US 20130261053 A1. 2013 October 03.

Facebook Icon - Twitter icon

Contact Us

(410) 292-8661:
qrliu1@gmail.com:

Dept. of Biology
300 Pompton Road
William Paterson University
Wayne, NJ 07470

Copyright (c) 2014 Neuro QR LLC, All Rights Reserved.